Table of Contents:
1 Introduction
1.1 Definition
1.2 Additional Facts & Figures
1.3 Scope of Study
1.4 Research Objective
1.5 Assumptions & Limitations
1.5.1 Assumptions
1.5.2 Limitations
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Increasing prevalence of dental diseases and dental trauma (impact Weightage - 45%)
3.2.2 Growing geriatric population (impact Weightage -15%)
3.2.3 Rising dental healthcare expenditures (impact Weightage - 40%)
3.3 Restraints
3.3.1 High cost (impact Weightage - 55%)
3.3.2 Prevalence of peri-implant mucositis and peri-implantitis (impact Weightage - 45%)
3.4 Opportunities
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Analysis
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Buyers
4.1.3 Threat of New Entrants
4.1.4 Threat of Substitutes
4.1.5 Intensity of Rivalry
4.2 Price Strategy Analysis
4.3 Supply Chain Analysis
4.4 Value Chain Analysis
4.4.1 Supporting Activity
4.4.2 Inbound Logistics
4.4.3 Operations
4.4.4 Marketing and sales
4.4.5 Outbound Logistics
4.4.6 Customer Services
5 Global Dental Implant Market, By Type of Material
5.1 Titanium Implant
5.2 Zirconium Implant
6 Global Dental Implant Market, By Procedure
6.1 Root Form Implant
6.2 Plate Form Implant
7 Global Dental Implant Market, By End User
7.1 Dental Hospitals & Clinics Market
7.2 Dental Research Laboratories
8 Global Dental Implant Market, By Region
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 UK
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest Of Europe
8.3 Asia-Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Republic of korea
8.3.5 Rest Of Asia-Pacific
8.4 Middle East & Africa
8.4.1 UAE
8.4.2 Saudi Arabia
8.4.3 Egypt
8.4.4 Rest of Middle East & Africa
9 Competitive Landscape
9.1 Market Share Analysis
10 Company Profile
10.1 3M
10.1.1 Company Overview
10.1.2 Financials
10.1.3 Products
10.1.4 Strategy
10.1.5 Key Developments
10.2 BEGO GmbH & Co. KG
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Products
10.2.4 Strategy
10.2.5 Key Developments
10.3 Bicon, LLC
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Products
10.3.4 Key Developments
10.4 CAMLOG Biotechnologies AG
10.4.1 Company Overview
10.4.2 Financials
10.4.3 Products
10.4.4 Strategy
10.4.5 Key Developments
10.5 Dentsply Sirona
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Products
10.5.4 Strategy
10.5.5 Key Developments
10.6 Implants Diffusion International
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Products
10.6.4 Strategy
10.6.5 Key Developments
10.7 Institut Straumann AG
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Products
10.7.4 Strategy
10.7.5 Key Developments
10.8 Danaher corporation
10.8.1 Company Overview
10.8.2 Financials
10.8.3 Products
10.8.4 Strategy
10.8.5 Key Developments
10.9 Osstem Implant Co., Ltd.
10.9.1 Company Overview
10.9.2 Financials
10.9.3 Products
10.9.4 Strategy
10.9.5 Key Developments
10.1 Sweden & Martina S.p.A.
10.10.1 Company Overview
10.10.2 Financials
10.10.3 Products
10.10.4 Strategy
10.10.5 Key Developments
10.11 Zimmer Biomet
10.11.1 Company Overview
10.11.2 Financials
10.11.3 Products
10.11.4 Strategy
10.11.5 Key Developments
11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO's View Point
12 Appendix
12.1 Discussion Blue Print
